References:
1. Dong E, Du H, Gardner L. An interactive web-based dashboard to track
COVID-19 in real time. The Lancet infectious diseases. 2020;20(5):533-4.
2. Elezkurtaj S, Greuel S, Ihlow J, Michaelis EG, Bischoff P, Kunze CA,
et al. Causes of death and comorbidities in hospitalized patients with
COVID-19. Scientific Reports. 2021;11(1):1-9.
3. Pandiar D, Kumar NS, Anand R, Kamboj M, Narwal A, Shameena P. Does
COVID 19 generate a milieu for propagation of mucormycosis? Medical
Hypotheses. 2021:110613.
4. Eucker J, Sezer O, Graf B, Possinger K. Mucormycoses. Mycoses.
2001;44(7‐8):253-60.
5. Dolatabadi S, Ahmadi B, Rezaei-Matehkolaei A, Zarrinfar H, Skiada A,
Mirhendi H, et al. Mucormycosis in Iran: A six-year retrospective
experience. Journal de mycologie medicale. 2018;28(2):269-73.
6. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease.
Clinical microbiology reviews. 2000;13(2):236-301.
7. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of
mucormycosis. Clinical Infectious Diseases. 2012;54(suppl_1):S16-S22.
8. John TM, Jacob CN, Kontoyiannis DP. When uncontrolled diabetes
mellitus and severe COVID-19 converge: the perfect storm for
mucormycosis. Journal of Fungi. 2021;7(4):298.
9. Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a
systematic review of cases reported worldwide and in India. Diabetes &
Metabolic Syndrome: Clinical Research & Reviews. 2021.
10. Alekseyev K, Didenko L, Chaudhry B. Rhinocerebral mucormycosis and
COVID-19 pneumonia. Journal of medical cases. 2021;12(3):85.
11. Waizel-Haiat S, Guerrero-Paz JA, Sanchez-Hurtado L, Calleja-Alarcon
S, Romero-Gutierrez L. A case of fatal rhino-orbital mucormycosis
associated with new onset diabetic ketoacidosis and COVID-19. Cureus.
2021;13(2).
12. Hanley B, Naresh KN, Roufosse C, Nicholson AG, Weir J, Cooke GS, et
al. Histopathological findings and viral tropism in UK patients with
severe fatal COVID-19: a post-mortem study. The Lancet Microbe.
2020;1(6):e245-e53.
13. Mehta S, Pandey A. Rhino-orbital mucormycosis associated with
COVID-19. Cureus. 2020;12(9).
14. do Monte Junior ES, Dos Santos MEL, Ribeiro IB, de Oliveira Luz G,
Baba ER, Hirsch BS, et al. Rare and fatal gastrointestinal mucormycosis
(Zygomycosis) in a COVID-19 patient: a case report. Clinical endoscopy.
2020;53(6):746.
15. Placik DA, Taylor WL, Wnuk NM. Bronchopleural fistula development in
the setting of novel therapies for acute respiratory distress syndrome
in SARS-CoV-2 pneumonia. Radiology Case Reports. 2020;15(11):2378-81.
16. Werthman-Ehrenreich A. Mucormycosis with orbital compartment
syndrome in a patient with COVID-19. The American journal of emergency
medicine. 2021;42:264. e5-. e8.
17. Mekonnen ZK, Ashraf DC, Jankowski T, Grob SR, Vagefi MR, Kersten RC,
et al. Acute invasive rhino-orbital mucormycosis in a patient with
COVID-19-associated acute respiratory distress syndrome. Ophthalmic
plastic and reconstructive surgery. 2021;37(2):e40.
18. Pasero D, Sanna S, Liperi C, Piredda D, Branca GP, Casadio L, et al.
A challenging complication following SARS-CoV-2 infection: a case of
pulmonary mucormycosis. Infection. 2020:1-6.
19. Zurl C, Hoenigl M, Schulz E, Hatzl S, Gorkiewicz G, Krause R, et al.
Autopsy proven pulmonary mucormycosis due to Rhizopus microsporus in a
critically ill COVID-19 patient with underlying hematological
malignancy. Journal of Fungi. 2021;7(2):88.
20. Veisi A, Bagheri A, Eshaghi M, Rikhtehgar MH, Rezaei Kanavi M,
Farjad R. Rhino-orbital mucormycosis during steroid therapy in COVID-19
patients: a case report. European Journal of Ophthalmology.
2021:11206721211009450.
21. Karimi‐Galougahi M, Arastou S, Haseli S, editors. Fulminant
mucormycosis complicating coronavirus disease 2019 (COVID‐19).
International forum of allergy & rhinology; 2021: Wiley Online Library.
22. Tabarsi P, Khalili N, Pourabdollah M, Sharifynia S, Naeini AS,
Ghorbani J, et al. COVID-19 associated rhinosinusitis mucormycosis due
to Rhizopus oryzae: A rare but potentially fatal infection occurring
after treatment with corticosteroids. 2021.
23. Gupta S, Goyal R, Kaore NM. Rhino-orbital-cerebral mucormycosis:
battle with the deadly enemy. Indian Journal of Otolaryngology and Head
& Neck Surgery. 2020;72(1):104-11.
24. Bawankar P, Lahane S, Pathak P, Gonde P, Singh A. Central retinal
artery occlusion as the presenting manifestation of invasive
rhino-orbital-cerebral mucormycosis. Taiwan journal of ophthalmology.
2020;10(1):62.
25. Hirabayashi KE, Idowu OO, Kalin-Hajdu E, Oldenburg CE, Brodie FL,
Kersten RC, et al. Invasive fungal sinusitis: risk factors for visual
acuity outcomes and mortality. Ophthalmic Plastic & Reconstructive
Surgery. 2019;35(6):535-42.